Rafik Bekkat-Berkani (United States of America)

GSK Biologicals, Inc. None

Poster Author Of 5 e-Posters

 e-Posters
AS02.a. Population studies and surveillance

EP040 - EVOLVING MENINGOCOCCAL IMMUNISATION LANDSCAPE, REMAINING GAPS AND CONSIDERATIONS FOR FUTURE LIFELONG IMMUNISATION (ID 892)

Session Name
0772 - E-Poster Viewing (ID 124)
Presenter
Authors
My link to connect
Veronique.x.abitbol@gsk.com
Availability (Date and Time)
Wednesday
AS03.b. Vaccine development (phase 1-2) – bacterial and all non-viral

EP072 - PUBLIC HEALTH PERSPECTIVE OF A PENTAVALENT MENINGOCOCCAL ABCWY VACCINE COMBINING ANTIGENIC COMPONENTS OF MENACWY-CRM AND 4CMENB VACCINES: PROGRESSING TOWARDS A MENINGOCOCCAL-FREE WORLD (ID 582)

Session Name
0772 - E-Poster Viewing (ID 124)
Presenter
Authors
AS03.e. Vaccine safety (post licensure)

EP083 - SAFETY AND IMMUNOGENICITY OF CO-ADMINISTERED MENINGOCOCCAL SEROGROUP B VACCINE (4CMENB) AND USE OF PROPHYLACTIC PARACETAMOL IN INFANTS AND TODDLERS: A LITERATURE REVIEW (ID 621)

Session Name
0772 - E-Poster Viewing (ID 124)
Presenter
Authors
AS03.f. Vaccine hesitancy

EP086 - KNOWLEDGE GAPS IN PARENTAL UNDERSTANDING OF INVASIVE MENINGOCOCCAL DISEASE AND ASSOCIATED VACCINES: RESULTS FROM A GLOBAL QUESTIONNAIRE (ID 590)

Session Name
0772 - E-Poster Viewing (ID 124)
Presenter
Authors
AS07.d. Sepsis, systemic and multi-organ infections

EP242 - NARRATIVE OF PUBLISHED EXPERIENCE OF A DIVERSE SPECTRUM OF INVASIVE MENINGOCOCCAL DISEASE (IMD) IN PAEDIATRIC AND ADOLESCENT PATIENTS (ID 1182)

Session Name
0772 - E-Poster Viewing (ID 124)
Presenter
Authors